Thanks for the link. There’s one in there as well for the trial which is cool. I think I might pass this on to someone I follow who specialises in this area and see feedback. Considering they’re targeting mRNA in this trial and dna in others, it’s astonishing to see comment of 3-5 years for availability after a “successful trial”. Extremely cavalier. As a Brit and seeing some of the BSE mess (note it was probably worse in France but for some reason never made the headlines), I understand the desire for speed but considering the timing with current evidence slowly coming out that we have a potential new prion problem post 2021. It’s a little unnerving to see such a short follow up. Maybe am a little conservative and if only used in people suffering obvious disease, it’s a good thing. It’s a damned thought to diagnose early though